• Home
  • What we do
  • About Us
  • Papers
  • Contact Us
  • The Inventor of Email™

Received FDA allowance for multi-combination drug

A new system for integrating an ensemble of distributed biochemical network models is presented. Rapid growth in the number of biochemical network models, created in different formats, across different computing systems, with minimal input and output information, necessitates the need for such a system in order to build large scale models in a flexible and scalable manner.  

read more
Received FDA allowance for multi-combination drug

Filed patent for multi-comb drug

Providing technology and services towards accelerating drug development using an integrative platform for quantitative modeling of complex molecular pathways. Using in-silico modeling to bridge in-vitro testing to human clinical trials with the goal of eliminating animal experimentation.

read more
Filed patent for multi-comb drug

Ready for proceeding to clinical trials

Biomolecular pathways are building blocks of cellular biochemical function. Computational biology is in rapid transition from diagrammatic representation of pathways to quantitative and predictive mathematical models, which span time-scales, knowledge domains and spatial-scales. This transition is being accelerated by high-throughput experimentation which isolates reactions and their corresponding rate constants.

read more
Ready for proceeding to clinical trials
Previous Next
Received FDA allowance for multi-combination drug

Received FDA allowance fo...

"A new system for integrating an ensemble of distributed biochemical network...

Filed patent for multi-comb drug

Filed patent for multi-co...

"Providing technology and services towards accelerating drug development using...

Ready for proceeding to clinical trials

Ready for proceeding to c...

"Biomolecular pathways are building blocks of cellular biochemical function....

Received FDA allowance for multi-combination drug

A new system for integrating an ensemble of distributed biochemical network models is presented. Rapid growth in the number of biochemical network models, created in different formats, across different computing systems, with minimal input and output information, necessitates the need for such a system in order to build large scale models in a flexible and scalable manner.

 

Read more

From Molecules to Market

Biomolecular pathways are building blocks of cellular biochemical function. Computational biology is in rapid transition from diagrammatic representation of pathways to quantitative and predictive mathematical models, which span time-scales, knowledge domains and spatial-scales. This transition is being accelerated by high-throughput experimentation which isolates reactions and their corresponding rate constants.

Read more

Papers

Information about development of CannabiSolve™ has evinced keen interest among the research community world-wide.  A number of papers has been written on the CannabiSolve™ platform and its components.  Researchers in the fields of computational biology and development of drug and treatment plans are using CannabiSolve™ to build their thesis.

You can view and read papers published on CannabiSolve™ and papers published by other researchers that cite CannabiSolve™ on this page.

Read more

News

02/21/13 Thomas Zawacki, entrepreneur and internet marketing specialist, joined the CannabiSolve board

01/18/13 Deepak Chopra, the famous alternative medicine expert and author, joins the board of CannabiSolve, Inc.

10/19/12 CannabiSolve, Inc. completed first round of angel investment

(c) 2005 - 2025 CannabiSolve, Inc. All rights reserved.
A CytoSolve Company